Hovione allies with Zerion to boost oral drug bioavailabilitynews2022-03-01T14:36:25+00:00March 1st, 2022|Fierce Pharma|
CureVac launches ‘RNA Printer’ subsidiary to provide clients with flexible mRNA manufacturingnews2022-03-01T13:44:51+00:00March 1st, 2022|Fierce Pharma|
Mindy Kaling becomes the face of national ‘PurpleStride’ pancreatic cancer fundraiser with backing from Ipsen, AbbVienews2022-03-01T13:36:57+00:00March 1st, 2022|Fierce Pharma|
AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ononews2022-03-01T13:06:31+00:00March 1st, 2022|Fierce Pharma|
Johnson & Johnson goes early on myasthenia gravis awareness push, eyeing argenx, AstraZeneca battle aheadnews2022-03-01T12:07:48+00:00March 1st, 2022|Fierce Pharma|
Johnson & Johnson, Legend’s CAR-T Carvykti enters myeloma ring with FDA nodnews2022-02-28T17:59:35+00:00February 28th, 2022|Fierce Pharma|
COPD Foundation links arms with Ena on antiviral nasal spray ahead of phase 2 trials in COVID-19, flunews2022-02-28T16:31:27+00:00February 28th, 2022|Fierce Pharma|
Trevi revs up extended-release opioid cough program, exiting phase 2 early and racing into next stagenews2022-02-28T16:28:04+00:00February 28th, 2022|Fierce Pharma|
Sanofi chases fourth Dupixent nod after late-stage eosinophilic esophagitis trial winnews2022-02-28T15:52:42+00:00February 28th, 2022|Fierce Pharma|
Lexicon pulls FDA submission for sotagliflozin to fix ‘technical issue,’ plans prompt refilingnews2022-02-28T15:34:59+00:00February 28th, 2022|Fierce Pharma|
